Received Mar 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | KB2YT | IM / LA |
PATIENT REPORTS FEELING VERY "UNDER THE WEATHER" FOR 7 DAYS, AS THEY WERE VACCINATED ON A FRIDAY AND REPORTS NOT LEAVING THEIR HOUSE UNTIL THE FOLLOWING FRIDAY, 2/21/25. PATIENT EXPERIENCED THE FOLLOWING (REPORTED BY PATIENT AS SEVERE) EVENTS: 102 DEGREE FEVER, SEVERE CHILLS, NAUSEA, HEADACHE, FLU SYMPTOMS, AND EYE PAIN. PATIENT REPORTS THEIR EYE TISSUES BEING UNUSUALLY RED (NOT THE ACTUAL EYEBALL, BUT THE TISSUES WITHIN EYE ORBIT) AND WERE LEAKING/RUNNING SO BAD AND WERE SO PAINFUL, PATIENT REPORTS THINKING THEIR EYES WERE BLEEDING. PATIENT DOES NOT RECALL HOW LONG THE EYE PAIN & WATERING LASTED BUT DID CONSULT WITH HER OPTOMETRIST.
NO KNOWN ILLNESS PER PATIENT
ESSENTIAL PRIMARY HYPERTENSION, MIXED HYPERLIPIDEMIA, ADULT MOOD DISORDER
AMLODIPINE BESYLATE 5 MG TABLET, EZETIMIBE 10 MG TABLET, LAMOTRIGINE 100 MG TABLET, LAMOTRIGINE 25 MG TABLET, QUETIAPINE FUMARATE 25 MG TABLET, ROSUVASTATIN 5 MG TABLET. NO OTC, SUPPLEMENTS OR HERBALS PER PATIENT.
NO KNOWN ALLERGIES PER PATIENT
N/A. PATIENT REPORTED TO VACCINATING PHARMACIST ON 3/23/25 AT APPROXIMATELY 3:15 PM.
PATIENT REPORTS HAVING A REACTION TO AN INFLUENZA VACCINATION IN 2022. PATIENT REPORTS DIFFICULTY BREATHING 1 HOUR AFTER RECEIVI